1. Home
  2. ENOV vs CGAU Comparison

ENOV vs CGAU Comparison

Compare ENOV & CGAU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ENOV
  • CGAU
  • Stock Information
  • Founded
  • ENOV 1995
  • CGAU 2002
  • Country
  • ENOV United States
  • CGAU Canada
  • Employees
  • ENOV N/A
  • CGAU N/A
  • Industry
  • ENOV Fluid Controls
  • CGAU Precious Metals
  • Sector
  • ENOV Industrials
  • CGAU Basic Materials
  • Exchange
  • ENOV Nasdaq
  • CGAU Nasdaq
  • Market Cap
  • ENOV 1.7B
  • CGAU 1.5B
  • IPO Year
  • ENOV 2008
  • CGAU N/A
  • Fundamental
  • Price
  • ENOV $26.48
  • CGAU $7.00
  • Analyst Decision
  • ENOV Strong Buy
  • CGAU Buy
  • Analyst Count
  • ENOV 5
  • CGAU 2
  • Target Price
  • ENOV $55.60
  • CGAU $13.00
  • AVG Volume (30 Days)
  • ENOV 1.7M
  • CGAU 830.3K
  • Earning Date
  • ENOV 08-07-2025
  • CGAU 08-06-2025
  • Dividend Yield
  • ENOV N/A
  • CGAU 2.87%
  • EPS Growth
  • ENOV N/A
  • CGAU N/A
  • EPS
  • ENOV N/A
  • CGAU 0.18
  • Revenue
  • ENOV $2,150,191,000.00
  • CGAU $1,208,123,000.00
  • Revenue This Year
  • ENOV $8.23
  • CGAU N/A
  • Revenue Next Year
  • ENOV $6.18
  • CGAU $8.11
  • P/E Ratio
  • ENOV N/A
  • CGAU $37.89
  • Revenue Growth
  • ENOV 18.32
  • CGAU 2.88
  • 52 Week Low
  • ENOV $26.31
  • CGAU $5.41
  • 52 Week High
  • ENOV $49.83
  • CGAU $7.82
  • Technical
  • Relative Strength Index (RSI)
  • ENOV 42.48
  • CGAU 44.04
  • Support Level
  • ENOV $29.74
  • CGAU $7.06
  • Resistance Level
  • ENOV $36.82
  • CGAU $7.28
  • Average True Range (ATR)
  • ENOV 1.39
  • CGAU 0.20
  • MACD
  • ENOV -0.30
  • CGAU -0.03
  • Stochastic Oscillator
  • ENOV 16.77
  • CGAU 3.57

About ENOV Enovis Corporation

Enovis Corp is a medical technology company that offers medical devices and services across the continuum of patient care, from injury prevention to joint replacement to rehabilitation after surgery, injury, or degenerative disease. Its reportable segments are Prevention & Recovery (P&R) and Reconstructive (Recon). The company generates the maximum revenue from the Prevention & Recovery segment, which includes products that are used to treat patients with musculoskeletal conditions resulting from degenerative diseases, deformities, traumatic events, and sports-related injuries. The Reconstructive segment provides a suite of reconstructive joint products for the hip, knee, shoulder, elbow, foot, ankle, and surgical productivity tools. Geographically, it derives key revenue from the U.S.

About CGAU Centerra Gold Inc.

Centerra Gold Inc a gold mining and exploration company engaged in the operation, exploration, development, and acquisition of gold properties in Asia, North America, and other markets world-wide. The company reportable operating segments are Oksut; Mount; and Milligan Molybdenum. It derives maximum revenue from Oksut segment. Geographically, it operates in Turkey, United States, Canada and Other.

Share on Social Networks: